Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the USMachaon M Bonafede, Barbara H Johnson, Crystal Watson
Pediatric Blood & Cancer|March 18, 2014
Patterns of symptoms and functional impairments in children with cancerTyler W Buckner, Jichuan Wang, Darren A DeWalt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 22, 2025
Approaches to Identify People With Haemophilia With Medicare Claims DataStacey A Fedewa, Tyler W Buckner, Lorraine Cafuir, et al.
Seminars in Thrombosis and Hemostasis|June 29, 2006
Current and future approaches to inhibitor management and aversionCharles Hay, Michael Recht, Manuel Carcao, et al.
Academic Radiology|January 31, 2021
Impact of COVID-19 Workflow Changes on Patient Throughput at Outpatient Imaging CentersGregory Chang, Ankur Doshi, Hersh Chandarana, et al.
Health Security|October 20, 2018
Federal Funding for Health Security in FY2019Crystal Watson, Matthew Watson, Daniel Gastfriend, et al.
Journal of Medical Economics|November 26, 2014
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in SwedenKen O'Day, Kellie Meyer, Dana Stafkey-Mailey, et al.
Pageof 21